Weber Christophe Pierre
SEC insider (Form 3/4/5 filer). CIK 0002011270. President and CEO at TAKEDA PHARMACEUTICAL CO LTD (TAK) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on May 7, 2026. Located in TOKYO.
Companies Weber Christophe Pierre has filed insider reports for
- TAKEDA PHARMACEUTICAL CO LTD (TAK): Director, Officer, President and CEO
- BOSTON SCIENTIFIC CORP (BSX): Director
Weber Christophe Pierre
CIK: 0002011270
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)6 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- May 7, 2026BSX
BOSTON SCIENTIFIC CORP
AwardDirect1.8K shares- - May 7, 2026BSX
BOSTON SCIENTIFIC CORP
AwardDirect1.1K shares- - Apr 27, 2026TAK
TAKEDA PHARMACEUTICAL CO LTD
AwardDirect78.9K shares- - Apr 27, 2026TAK
TAKEDA PHARMACEUTICAL CO LTD
AwardDirect165.4K shares- - Mar 2, 2026BSX
BOSTON SCIENTIFIC CORP
AwardDirect556 shares- - Mar 2, 2026BSX
BOSTON SCIENTIFIC CORP
AwardDirect323 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 7, 2026 |  BSX BOSTON SCIENTIFIC CORP | Award | 1,767 | - | $0 | Direct |
| May 7, 2026 | BSX BOSTON SCIENTIFIC CORP | Award | 1,140 | - | $0 | Direct |
| Apr 27, 2026 |  TAK TAKEDA PHARMACEUTICAL CO LTD | Award | 78,900 | - | $0 | Direct |
| Apr 27, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | Award | 165,370 | - | $0 | Direct |
| Mar 2, 2026 | BSX BOSTON SCIENTIFIC CORP | Award | 556 | - | $0 | Direct |
| Mar 2, 2026 | BSX BOSTON SCIENTIFIC CORP | Award | 323 | - | $0 | Direct |
1-6 of 6 transactions